Education
About Us
Working with TipRanks
Follow Us
Predictmedix (PMEDF)
OTHER OTC:PMEDF
PMEDF Stock Chart & Stats
$0.04
$0.00(0.00%)
At close: 4:00 PM EST
$0.04
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.07
Previous CloseN/A
Volume20.00
Average Volume (3M)23.73K
Market Cap
$6.85M
Enterprise Value$11.06M
Total Cash (Recent Filing)$313.74K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.04
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding206,787,540
10 Day Avg. Volume12,646
30 Day Avg. Volume23,728
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-1.71
Price to Sales (P/S)0.00
P/FCF Ratio-61.13
Enterprise Value/Market Cap1.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-206.53
Enterprise Value/Ebitda-13.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Reported DebtNear-zero reported debt provides structural financial flexibility relative to highly leveraged peers. Over the next 2–6 months this reduces insolvency risk, eases interest burdens, and increases optionality to raise capital or invest in product development without heavy fixed financing costs.
Narrowing Cash BurnA material reduction in cash burn in 2025 versus 2024 indicates improving operational discipline or cost control. If sustained, this durable trend extends runway, lowers near-term financing reliance, and supports incremental investments toward commercial traction or product refinement.
AI-driven Digital Health NicheOperating in AI-enabled, contactless health screening targets a structural shift toward remote assessment and workplace screening. This market positioning offers durable demand tailwinds and scope for differentiated product adoption if the company proves accuracy and regulatory compliance over time.
Bears Say
Negative Shareholders' EquityDeeply negative equity reflects cumulative losses and materially weakens the balance sheet. Over months this limits financial flexibility, can impair counterparty confidence, restricts access to traditional financing, and raises the likelihood of dilutive recapitalizations if revenues don't stabilize.
Consistent Negative Cash GenerationPersistent negative operating and free cash flow indicate the core business does not self-fund activities. This structural cash burn requires ongoing external financing, increases dilution or creditor risk, and undermines long-term viability absent a clear, sustained revenue inflection.
Minimal, Inconsistent Revenue And Large LossesThe company lacks a stable revenue base and shows very large operating losses, signaling no clear path to sustained profitability. Over 2–6 months this structural shortfall hampers reinvestment, commercial scaling, and the ability to demonstrate unit economics critical for durable growth.
Predictmedix News
PMEDF FAQ
What was Predictmedix’s price range in the past 12 months?
Predictmedix lowest stock price was $0.01 and its highest was $0.07 in the past 12 months.
What is Predictmedix’s market cap?
Predictmedix’s market cap is $6.85M.
When is Predictmedix’s upcoming earnings report date?
Predictmedix’s upcoming earnings report date is Jun 03, 2026 which is in 86 days.
How were Predictmedix’s earnings last quarter?
Predictmedix released its earnings results on Dec 19, 2025. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is Predictmedix overvalued?
According to Wall Street analysts Predictmedix’s price is currently Overvalued.
Does Predictmedix pay dividends?
Predictmedix does not currently pay dividends.
What is Predictmedix’s EPS estimate?
Predictmedix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predictmedix have?
Predictmedix has 206,787,540 shares outstanding.
What happened to Predictmedix’s price movement after its last earnings report?
Predictmedix reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -28.571%.
Which hedge fund is a major shareholder of Predictmedix?
Currently, no hedge funds are holding shares in PMEDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Predictmedix
Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offers disease symptom screening solutions to identify persons who are more likely to test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. The company also develops impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.
Technical Analysis
Imagin Medical
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
VentriPoint Diagnostics
―
Cannabix Technologies
―
Ownership Overview
Options Prices
Currently, No data available
---